4-Bromo-2-(trifluoromethyl)aniline(CAS: 445-02-3)

4-Bromo-2-(trifluoromethyl)aniline (CAS: 445-02-3) is subject to regulation under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for its potential hazards. In Europe, it is governed by the REACH regulations. It is also regulated by the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) for its safety and environmental impact. Companies must ensure compliance with these guidelines by providing proper labeling, safety data sheets, and handling procedures.

While 4-Bromo-2-(trifluoromethyl)aniline (CAS: 445-02-3) is a specific compound, there are alternative reagents that can be used in its synthesis. For instance, 4-Chloro-2-(trifluoromethyl)aniline can be used as a bromine analog. Other alternatives include using different functional groups or modifying the substituents to achieve similar chemical properties without the bromine moiety.

The research and market trends for 4-Bromo-2-(trifluoromethyl)aniline (CAS: 445-02-3) are focused on its use in the preparation of pharmaceutical intermediates and organofluorine chemistry. Recent studies have explored its role in developing new drug candidates. The market is growing due to increasing demand from the pharmaceutical industry. Research is also expanding into its applications in organic synthesis and material science.

Waste containing 4-Bromo-2-(trifluoromethyl)aniline (CAS: 445-02-3) should be collected in appropriate containers and labeled with the correct hazard information. It should be handled according to the guidelines outlined in the safety data sheet (SDS). For disposal, the waste should be incinerated in a controlled environment or managed by a professional hazardous waste disposal service. Environmental precautions include ensuring no discharge of the waste into water bodies and minimizing exposure to air and soil to prevent contamination.